Lupin Ltd LUPIN-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 4:56 PM IST
1,008.30quote price arrow down-2.20 (-0.22%)
Volume
947,886
52 week range
504.75 - 1,122.30

...

Loading . . .

KEY STATS

  • Open1,016.00
  • Day High1,019.55
  • Day Low990.10
  • Prev Close1,010.50
  • 52 Week High1,122.30
  • 52 Week High Date09/18/20
  • 52 Week Low504.75
  • 52 Week Low Date03/13/20
  • Market Cap6,385.81M
  • Shares Out453.24M
  • 10 Day Average Volume2.28M
  • Dividend6.00
  • Dividend Yield0.60%
  • Beta
  • 1 Year % Change49.88

RATIOS/PROFITABILITY

  • EPS (TTM)25.29
  • P/E (TTM)39.87
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date08/03/2020
  • Div Amount6.00
  • Split Date-
  • Split Factor-

Latest Lupin Ltd News

There is no recent news for this security.

Latest LUPIN-IN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Lupin Limited is a pharmaceutical company. The Company is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world. The Company offers products in the cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastro-intestinal, anti-infectives and non-steroidal anti-inflammatory drug therapy areas. The Company also offers solutions in the...
Manju Gupta
Chairman
Vinita Gupta
Chief Executive Officer
Ramesh Swaminathan
Chief Financial Officer
Address
B/4 Laxmi Towers
, Bandra Kurla Complex, Bandra (E)
Mumbai
400051
India